Although research on SVOPL is limited, it may play a role in epigenetic dysregulation via allelic switching in colorectal cancer, while in breast cancer, higher expression appears linked to better treatment response and prognosis [56,57]. The gene discussed is SVOPL; the disease is colorectal cancer.